A prognostic study of patient who completed Study 0761-003; a randomized late phase II study of VCAP/AMP/VECP (mLSG15) and mLSG15+KW-0761 in patients with CCR4-positive adult T-Cell leukemia-lymphoma (untreated primary disease)

A prognostic study of patient who completed Study 0761-003; a randomized late phase II study of VCAP/AMP/VECP (mLSG15) and mLSG15+KW-0761 in patients with CCR4-positive adult T-Cell leukemia-lymphoma (untreated primary disease) - A prognostic study of patient who completed Study 0761-003; a randomized late phase II study of VCAP/AMP/VECP (mLSG15) and mLSG15+KW-0761 in patients with CCR4-positive adult T-Cell leukemia-lymphoma (untreated primary disease)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013294

Enrollment

Registered

2014-03-01

Start date

2013-10-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult T-cell leukemia-lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Those who participated in Study 0761-003.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Progression-free survival Overall survival	—

Countries

Japan

Contacts

Public ContactSatoshi Yurimoto

Kyowa Hakko Kirin Co., Ltd Medical Affairs Department

ma.oncology@kyowa-kirin.co.jp07031413339

Outcome results